Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)
INR 1806.5
(0.3%)
INR 1806.5
(0.3%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 104.3 Billion INR | 12.1% |
| 2022 | 93.04 Billion INR | 14.21% |
| 2021 | 81.47 Billion INR | 26.75% |
| 2020 | 64.27 Billion INR | 29.91% |
| 2019 | 49.47 Billion INR | 4.44% |
| 2018 | 47.37 Billion INR | 15.91% |
| 2017 | 40.86 Billion INR | -52.19% |
| 2016 | 85.49 Billion INR | 14.62% |
| 2015 | 74.58 Billion INR | 8.95% |
| 2014 | 68.45 Billion INR | 1.46% |
| 2013 | 67.47 Billion INR | 46.48% |
| 2012 | 46.06 Billion INR | 55.06% |
| 2011 | 29.7 Billion INR | 45.92% |
| 2010 | 20.35 Billion INR | 43.89% |
| 2009 | 14.14 Billion INR | -27.41% |
| 2008 | 19.49 Billion INR | 21.87% |
| 2007 | 15.99 Billion INR | 91.9% |
| 2006 | 8.33 Billion INR | 39.63% |
| 2005 | 5.96 Billion INR | 41.82% |
| 2004 | 4.2 Billion INR | 10.41% |
| 2003 | 3.81 Billion INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 30.02 Billion INR | 23.01% |
| 2024 Q2 | 31.84 Billion INR | 6.06% |
| 2023 Q4 | 24.41 Billion INR | -21.38% |
| 2023 Q3 | 31.04 Billion INR | 9.32% |
| 2023 Q2 | 28.4 Billion INR | 6.04% |
| 2023 Q1 | 26.78 Billion INR | 6.97% |
| 2023 FY | 104.3 Billion INR | 12.1% |
| 2022 FY | 93.04 Billion INR | 14.21% |
| 2022 Q4 | 25.03 Billion INR | -0.55% |
| 2022 Q2 | 24.31 Billion INR | 13.07% |
| 2022 Q1 | 21.5 Billion INR | 28.78% |
| 2022 Q3 | 25.17 Billion INR | 3.53% |
| 2021 Q4 | 16.7 Billion INR | -19.06% |
| 2021 FY | 81.47 Billion INR | 26.75% |
| 2021 Q1 | 22.37 Billion INR | 45.72% |
| 2021 Q2 | 21.75 Billion INR | -2.77% |
| 2021 Q3 | 20.63 Billion INR | -5.18% |
| 2020 FY | 64.27 Billion INR | 29.91% |
| 2020 Q4 | 15.35 Billion INR | -14.8% |
| 2020 Q3 | 18.02 Billion INR | -0.47% |
| 2020 Q2 | 18.11 Billion INR | 42.78% |
| 2020 Q1 | 12.68 Billion INR | 34.4% |
| 2019 Q1 | 14.71 Billion INR | 100.68% |
| 2019 Q2 | 13.07 Billion INR | -11.09% |
| 2019 FY | 49.47 Billion INR | 4.44% |
| 2019 Q3 | 12.12 Billion INR | -7.29% |
| 2019 Q4 | 9.43 Billion INR | -22.17% |
| 2018 Q2 | 11.04 Billion INR | -8.33% |
| 2018 FY | 47.37 Billion INR | 15.91% |
| 2018 Q4 | 7.33 Billion INR | -56.41% |
| 2018 Q3 | 16.81 Billion INR | 52.24% |
| 2018 Q1 | 12.05 Billion INR | -1.89% |
| 2017 Q1 | 7.49 Billion INR | -38.06% |
| 2017 FY | 40.86 Billion INR | -52.19% |
| 2017 Q4 | 12.28 Billion INR | 10.25% |
| 2017 Q3 | 11.14 Billion INR | 9.55% |
| 2017 Q2 | 10.16 Billion INR | 35.77% |
| 2016 Q1 | 23.68 Billion INR | 16.36% |
| 2016 FY | 85.49 Billion INR | 14.62% |
| 2016 Q4 | 12.09 Billion INR | -36.91% |
| 2016 Q3 | 19.16 Billion INR | -18.87% |
| 2016 Q2 | 23.62 Billion INR | -0.25% |
| 2015 Q2 | 16.28 Billion INR | 18.49% |
| 2015 Q3 | 18.82 Billion INR | 15.63% |
| 2015 Q1 | 13.74 Billion INR | 328.43% |
| 2015 Q4 | 20.35 Billion INR | 8.12% |
| 2015 FY | 74.58 Billion INR | 8.95% |
| 2014 Q4 | 3.2 Billion INR | -81.99% |
| 2014 Q2 | 19.93 Billion INR | 24.95% |
| 2014 Q1 | 15.95 Billion INR | -7.01% |
| 2014 FY | 68.45 Billion INR | 1.46% |
| 2014 Q3 | 17.8 Billion INR | -10.68% |
| 2013 Q1 | 14.53 Billion INR | 20.39% |
| 2013 Q2 | 17.27 Billion INR | 18.89% |
| 2013 Q3 | 18.7 Billion INR | 8.23% |
| 2013 Q4 | 17.16 Billion INR | -8.23% |
| 2013 FY | 67.47 Billion INR | 46.48% |
| 2012 Q1 | 11.62 Billion INR | 31.42% |
| 2012 Q3 | 11.76 Billion INR | 8.39% |
| 2012 Q4 | 12.07 Billion INR | 2.6% |
| 2012 FY | 46.06 Billion INR | 55.06% |
| 2012 Q2 | 10.85 Billion INR | -6.58% |
| 2011 Q4 | 8.84 Billion INR | -0.24% |
| 2011 Q3 | 8.86 Billion INR | 23.57% |
| 2011 Q2 | 7.17 Billion INR | 20.92% |
| 2011 Q1 | 5.93 Billion INR | 0.0% |
| 2011 FY | 29.7 Billion INR | 45.92% |
| 2010 FY | 20.35 Billion INR | 43.89% |
| 2009 FY | 14.14 Billion INR | -27.41% |
| 2008 FY | 19.49 Billion INR | 21.87% |
| 2007 FY | 15.99 Billion INR | 91.9% |
| 2006 FY | 8.33 Billion INR | 39.63% |
| 2005 FY | 5.96 Billion INR | 41.82% |
| 2004 FY | 4.2 Billion INR | 10.41% |
| 2003 FY | 3.81 Billion INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Sigachi Industries Limited | 1.47 Billion INR | -6976.748% |
| Ind-Swift Limited | 1.22 Billion INR | -8407.909% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Sakar Healthcare Limited | 495.5 Million INR | -20949.977% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 0.191% |
| Innova Captab Limited | 2.53 Billion INR | -4017.135% |
| Divi's Laboratories Limited | 18.31 Billion INR | -469.655% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | -2231.386% |
| Morepen Laboratories Limited | 4.17 Billion INR | -2398.997% |
| Mankind Pharma Limited | 40.86 Billion INR | -155.224% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Wanbury Limited | 1.7 Billion INR | -6009.622% |
| Laurus Labs Limited | 3.94 Billion INR | -2541.541% |
| Nectar Lifesciences Limited | 3.89 Billion INR | -2580.928% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | -1061.618% |
| Alembic Limited | 767.77 Million INR | -13485.305% |
| Hikal Limited | 1.49 Billion INR | -6880.585% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | -1711.429% |
| Neuland Laboratories Limited | 5.31 Billion INR | -1861.303% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | -1283.04% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | -1504.088% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | -2010.475% |
| Themis Medicare Limited | 1.3 Billion INR | -7904.259% |
| RPG Life Sciences Limited | 2.29 Billion INR | -4450.185% |
| Zydus Lifesciences Limited | 45.39 Billion INR | -129.785% |
| Lupin Limited | 27.75 Billion INR | -275.76% |
| Amrutanjan Health Care Limited | 621.02 Million INR | -16695.389% |
| Wockhardt Limited | 140 Million INR | -74402.786% |
| Vaishali Pharma Limited | 6.29 Million INR | -1657095.742% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -3234.4% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | -48631.032% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -1910.096% |
| FDC Limited | 3.03 Billion INR | -3338.129% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | -54.002% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -50034.054% |
| Eris Lifesciences Limited | 5.18 Billion INR | -1912.92% |
| Venus Remedies Limited | 534.65 Million INR | -19408.782% |
| ZIM Laboratories Limited | 1.09 Billion INR | -9398.467% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -8373.096% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | -18809.714% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | -1343.593% |
| Shilpa Medicare Limited | 3.76 Billion INR | -2672.881% |
| Albert David Limited | 1.33 Billion INR | -7716.205% |
| Ajanta Pharma Limited | 19.67 Billion INR | -430.072% |
| Hester Biosciences Limited | 364.77 Million INR | -28494.429% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -2163.715% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 2807.153% |
| Gufic Biosciences Limited | 2.89 Billion INR | -3504.387% |
| Windlas Biotech Limited | 1.29 Billion INR | -7930.234% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -3643.859% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | -3684474.75% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -379767.07% |
| Granules India Limited | 6.52 Billion INR | -1497.729% |
| Aarti Drugs Limited | 7.14 Billion INR | -1359.057% |
| Bal Pharma Limited | 214.56 Million INR | -48510.89% |
| Alkem Laboratories Limited | 19.46 Billion INR | -435.939% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | -5371.456% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | -43787.68% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | -504856.913% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| Orchid Pharma Limited | 2.36 Billion INR | -4317.639% |
| Medico Remedies Limited | 277.11 Million INR | -37538.804% |
| Ind-Swift Laboratories Limited | 2 Billion INR | -5091.746% |
| Ipca Laboratories Limited | 29.59 Billion INR | -252.42% |
| Brooks Laboratories Limited | -72.25 Million INR | 144461.263% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -41746.933% |
| Piramal Enterprises Limited | - INR | -Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | -311.696% |
| NATCO Pharma Limited | 25.96 Billion INR | -301.756% |
| Suven Life Sciences Limited | -1.22 Billion INR | 8608.894% |
| Krebs Biochemicals & Industries Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | -1895.937% |
| Indoco Remedies Limited | 1.52 Billion INR | -6742.292% |
| Alpa Laboratories Limited | 61.51 Million INR | -169458.482% |
| Lasa Supergenerics Limited | -458 Million INR | 22873.529% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 2634.699% |